International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines
CEBU CITY, Philippines, June 17, 2025 /PRNewswire/ -- Anchanto, the leading global B2B SaaS technology company in e-commerce and supply chain, announced its latest partnership with International Pharmaceuticals, Inc. (IPI), one of Philippines'...
Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer
Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic. NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End...
Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025
HONG KONG, June 16, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") presented the subgroup analysis data from the Phase III COMPASSION-16 trial, evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody, in the...
Sentient Digital, Inc. (SDi) Partners with Viasat to Support Korea Coast Guard Maritime Domain Awareness and Information Sharing Missions
NEW ORLEANS, June 11, 2025 /PRNewswire/ -- Sentient Digital, Inc. (SDi), a leading provider of defense technology and engineering services, today announced our partnership with Viasat, a global leader in satellite communications, to deliver advanced...
Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates
SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the signing of a strategic cooperation agreement with...
Gemini Announces Confidential Submission of Draft Registration Statement for a Proposed Initial Public Offering
NEW YORK, June 7, 2025 /PRNewswire/ -- Gemini Space Station, Inc. ("Gemini") today announced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the...
FutureCeuticals, Inc. Announces Peer-Reviewed Publication Highlighting Cellular Health and Immune Support Benefits of vitAlign®
MOMENCE, Ill., June 5, 2025 /PRNewswire/ -- New research published in the International Journal of Molecular Sciences shows that vitAlign®, a proprietary and comprehensive healthy aging innovation from FutureCeuticals, delivers significant benefits...
Financing Agreement Signed for Rooftop Solar Power Project in Singapore
TOKYO, June 5, 2025 /PRNewswire/ -- Tokyo Electric Power Company Holdings, Inc. (hereinafter "TEPCO HD") is pleased to announce that a Special Purpose Vehicle (hereinafter "SPV"), established by TEPCO HD and ESR Group Limited*1 (hereinafter "ESR"),...
Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab
HONG KONG, June 5, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecific antibody,...
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 5, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...